Variant report

Variant	esv1823332
Chromosome Location	chr2:76796561-76859554
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:346)
CpG islands
(count:122)
Chromatin interactive
region (count:6)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:346 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:76826892-76827267	HepG2	liver:	n/a	n/a
2	BACH1	chr2:76826863-76827150	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr2:76826886-76827145	GM12878	blood:	n/a	n/a
4	BHLHE40	chr2:76826935-76827215	GM12878	blood:	n/a	n/a
5	BHLHE40	chr2:76826921-76827181	K562	blood:	n/a	n/a
6	BRCA1	chr2:76826858-76827249	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr2:76796956-76797326	HepG2	liver:	n/a	n/a
8	CEBPB	chr2:76797632-76797940	IMR90	lung:	n/a	chr2:76797773-76797790 chr2:76797774-76797787 chr2:76797774-76797785 chr2:76797775-76797786
9	CEBPB	chr2:76826891-76827167	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPB	chr2:76796996-76797228	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr2:76797647-76797927	A549	lung:	n/a	chr2:76797773-76797790 chr2:76797774-76797787 chr2:76797774-76797785 chr2:76797775-76797786
12	CEBPB	chr2:76797051-76797266	A549	lung:	n/a	n/a
13	CEBPB	chr2:76797598-76797957	HepG2	liver:	n/a	chr2:76797773-76797790 chr2:76797774-76797787 chr2:76797774-76797785 chr2:76797775-76797786
14	CEBPB	chr2:76797064-76797289	MCF-7	breast:	n/a	n/a
15	CEBPB	chr2:76797009-76797286	IMR90	lung:	n/a	n/a
16	CEBPB	chr2:76797619-76797897	K562	blood:	n/a	chr2:76797773-76797790 chr2:76797774-76797787 chr2:76797774-76797785 chr2:76797775-76797786
17	CHD1	chr2:76808522-76808533	GM12878	blood:	n/a	n/a
18	CHD2	chr2:76826886-76827202	H1-hESC	embryonic stem cell:	n/a	n/a
19	CREB1	chr2:76856448-76856731	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr2:76826980-76827130	GM12870	blood:	n/a	n/a
21	CTCF	chr2:76826980-76827130	AoAF	blood vessel:	n/a	n/a
22	CTCF	chr2:76827000-76827150	HA-sp	spinal cord:	n/a	n/a
23	CTCF	chr2:76826980-76827130	GM12865	blood:	n/a	n/a
24	CTCF	chr2:76826919-76827113	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr2:76826782-76827238	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr2:76826913-76827207	Kidney_OC	kidney:	n/a	n/a
27	CTCF	chr2:76826920-76827070	MCF-7	breast:	n/a	n/a
28	CTCF	chr2:76826760-76826910	AoAF	blood vessel:	n/a	n/a
29	CTCF	chr2:76826929-76827148	GM19240	blood:	n/a	n/a
30	CTCF	chr2:76827360-76827510	GM12864	blood:	n/a	n/a
31	CTCF	chr2:76827000-76827150	HEEpiC	esophagus:	n/a	n/a
32	CTCF	chr2:76827000-76827150	HepG2	liver:	n/a	n/a
33	CTCF	chr2:76826980-76827130	HCM	heart:	n/a	n/a
34	CTCF	chr2:76826940-76827090	GM12874	blood:	n/a	n/a
35	CTCF	chr2:76826622-76827481	A549	lung:	n/a	n/a
36	CTCF	chr2:76826920-76827070	A549	lung:	n/a	n/a
37	CTCF	chr2:76826980-76827130	GM06990	blood:	n/a	n/a
38	CTCF	chr2:76826960-76827110	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr2:76826912-76827249	Medullo	brain:	n/a	n/a
40	CTCF	chr2:76827780-76827930	K562	blood:	n/a	n/a
41	CTCF	chr2:76826940-76827090	WERI-Rb-1	eye:	n/a	n/a
42	CTCF	chr2:76826806-76827245	T-47D	breast:	n/a	n/a
43	CTCF	chr2:76826980-76827130	GM12864	blood:	n/a	n/a
44	CTCF	chr2:76826702-76827499	SK-N-SH	brain:	n/a	n/a
45	CTCF	chr2:76826911-76827150	GM19238	blood:	n/a	n/a
46	CTCF	chr2:76827020-76827170	HA-sp	spinal cord:	n/a	n/a
47	CTCF	chr2:76827320-76827470	GM12864	blood:	n/a	n/a
48	CTCF	chr2:76826818-76827279	HepG2	liver:	n/a	n/a
49	CTCF	chr2:76827000-76827150	NHDF-neo	bronchial:	n/a	n/a
50	CTCF	chr2:76826920-76827070	RPTEC	kidney:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:76806361-76806411	GM12892	blood:	n/a
2	chr2:76806361-76806411	AG04450	lung:	fetal
3	chr2:76806361-76806411	HEK293	kidney:	embryo
4	chr2:76806361-76806411	A549	lung:	n/a
5	chr2:76839078-76839128	HUVEC	blood vessel:	n/a
6	chr2:76839078-76839128	BE2_C	brain:	n/a
7	chr2:76806361-76806411	SK-N-SH_RA	brain:	n/a
8	chr2:76839078-76839128	SK-N-MC	brain:	n/a
9	chr2:76806361-76806411	MCF-7	breast:	n/a
10	chr2:76839078-76839128	SAEC	small airway:	n/a
11	chr2:76806361-76806411	HRE	kidney:	n/a
12	chr2:76806361-76806411	GM12878	blood:	n/a
13	chr2:76839078-76839128	T-47D	breast:	n/a
14	chr2:76806361-76806411	HCF	heart:	n/a
15	chr2:76839078-76839128	Jurkat	blood:	n/a
16	chr2:76806361-76806411	RPTEC	kidney:	n/a
17	chr2:76806361-76806411	HRCEpiC	kidney:	n/a
18	chr2:76839078-76839128	AG09309	skin:	n/a
19	chr2:76806361-76806411	GM12891	blood:	n/a
20	chr2:76839078-76839128	NHDF-neo	bronchial:	n/a
21	chr2:76839078-76839128	HEEpiC	esophagus:	n/a
22	chr2:76839078-76839128	HCT-116	colon:	n/a
23	chr2:76806361-76806411	HUVEC	blood vessel:	n/a
24	chr2:76806361-76806411	K562	blood:	n/a
25	chr2:76839078-76839128	MCF10A-Er-Src	breast:	n/a
26	chr2:76839078-76839128	SKMC	muscle:	n/a
27	chr2:76839078-76839128	LNCaP	prostate:	n/a
28	chr2:76806361-76806411	SK-N-MC	brain:	n/a
29	chr2:76839078-76839128	K562	blood:	n/a
30	chr2:76839078-76839128	PrEC	prostate:	n/a
31	chr2:76806361-76806411	AG04449	skin:	fetal
32	chr2:76839078-76839128	Hela-S3	cervix:	n/a
33	chr2:76806361-76806411	HNPCEpiC	eye:	n/a
34	chr2:76839078-76839128	RPTEC	kidney:	n/a
35	chr2:76839078-76839128	BJ	skin:	n/a
36	chr2:76806361-76806411	Hepatocyte	liver:	n/a
37	chr2:76839078-76839128	GM12878	blood:	n/a
38	chr2:76806361-76806411	BE2_C	brain:	n/a
39	chr2:76806361-76806411	Hela-S3	cervix:	n/a
40	chr2:76839078-76839128	HCM	heart:	n/a
41	chr2:76839078-76839128	GM12891	blood:	n/a
42	chr2:76839078-76839128	HEK293	kidney:	embryo
43	chr2:76839078-76839128	HRPEpiC	eye:	n/a
44	chr2:76806361-76806411	HCPEpiC	choroid plexus:	n/a
45	chr2:76839078-76839128	ECC-1	luminal epithelium:	n/a
46	chr2:76839078-76839128	U87	brain:	n/a
47	chr2:76806361-76806411	MCF10A-Er-Src	breast:	n/a
48	chr2:76806361-76806411	AG09319	gingival:	n/a
49	chr2:76806361-76806411	AoSMC	blood vessel:	n/a
50	chr2:76839078-76839128	HPAEpiC	pulmonary alveolar:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:76837968..76839669-chr2:76845469..76848246,2	MCF-7	breast:
2	chr2:76837968..76839669-chr2:76845469..76848246,2	MCF-7	breast:
3	chr2:76123697..76124563-chr2:76826531..76827162,2	MCF-7	breast:
4	chr2:75957100..75957649-chr2:76826627..76827405,2	MCF-7	breast:
5	chr2:76424788..76425711-chr2:76826568..76827565,9	MCF-7	breast:
6	chr2:76014514..76015446-chr2:76826422..76827585,4	MCF-7	breast:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MRPL19-18	chr2:76802723-76802739	NONHSAT071820
2	lnc-MRPL19-17	chr2:76805608-76805913	NONHSAT071819
3	lnc-MRPL19-18	chr2:76807165-76807212	NONHSAT071820
4	lnc-LRRTM4-5	chr2:76822539-76822804	NONHSAT071821
5	lnc-MRPL19-18	chr2:76814741-76814827	NONHSAT071820
6	lnc-MRPL19-18	chr2:76806776-76806856	NONHSAT071820
7	lnc-MRPL19-17	chr2:76802439-76802582	NONHSAT071819

No data

Variant related genes	Relation type
RN7SKP164	TF binding region
RN7SKP164	CpG island

Extended variants
information (count: 2985 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:2985 , 50 per page) page: 1 2 3 4 5 6 7 ... 60

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs963552	chr2:76796561-76796562	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs373424986	chr2:76796604-76796605	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs115852607	chr2:76796618-76796619	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs540624889	chr2:76796674-76796675	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs140996941	chr2:76796697-76796698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs184465191	chr2:76796749-76796750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs201920139	chr2:76796768-76796769	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs75032820	chr2:76796812-76796813	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs549635587	chr2:76796835-76796836	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs532405827	chr2:76796847-76796848	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs532092916	chr2:76796862-76796863	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs550441397	chr2:76796864-76796865	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs571806087	chr2:76796871-76796872	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs539026010	chr2:76796946-76796947	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs556363307	chr2:76797020-76797021	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs188210191	chr2:76797026-76797027	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs116269832	chr2:76797051-76797052	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs144842113	chr2:76797074-76797075	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs192789339	chr2:76797114-76797115	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs575827457	chr2:76797118-76797119	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs377549915	chr2:76797119-76797120	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs543350467	chr2:76797132-76797133	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs558819765	chr2:76797156-76797157	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs577037281	chr2:76797168-76797169	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs11887907	chr2:76797171-76797172	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs565699259	chr2:76797192-76797193	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs11887831	chr2:76797193-76797194	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs541943885	chr2:76797194-76797195	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs11887917	chr2:76797206-76797207	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs531952518	chr2:76797234-76797235	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs550058876	chr2:76797270-76797271	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs13392712	chr2:76797322-76797323	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs532661216	chr2:76797324-76797325	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs78102399	chr2:76797340-76797341	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs147920473	chr2:76797344-76797345	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs139565712	chr2:76797362-76797363	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs554631890	chr2:76797393-76797394	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs185279840	chr2:76797431-76797432	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs534143736	chr2:76797435-76797436	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs564143424	chr2:76797451-76797452	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs531856463	chr2:76797457-76797458	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs377484683	chr2:76797470-76797471	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs117584324	chr2:76797471-76797472	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs558434718	chr2:76797474-76797475	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs13418079	chr2:76797476-76797477	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs73938474	chr2:76797487-76797488	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs529443414	chr2:76797511-76797512	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs78233244	chr2:76797521-76797522	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs189077683	chr2:76797522-76797523	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs145080885	chr2:76797552-76797553	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Lung cancer	18438408	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Renal cell carcinoma	18765545	CNVD
Myxofibrosarcoma	16751306	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Mental retardation	17124404	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Cancer	17440070	CNVD
Myelofibrosis	22110671	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Breast cancer	16272173	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20531469	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:257 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:76776000-76807000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:76793000-76796600	Weak transcription	Liver	Liver
3	chr2:76793800-76798800	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr2:76795000-76797200	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr2:76795200-76797000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr2:76795400-76796800	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr2:76796600-76796800	Enhancers	Liver	Liver
8	chr2:76796800-76797200	Active TSS	Pancreatic Islets	Pancreatic Islet
9	chr2:76796800-76797600	Flanking Active TSS	Liver	Liver
10	chr2:76796800-76797800	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr2:76796800-76800000	Enhancers	HUES6 Cell Line	embryonic stem cell
12	chr2:76796800-76800600	Enhancers	HUES48 Cell Line	embryonic stem cell
13	chr2:76797000-76797600	Enhancers	Pancreas	Pancrea
14	chr2:76797000-76797800	Enhancers	Fetal Heart	heart
15	chr2:76797000-76800800	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr2:76797200-76797600	Enhancers	H9 Cell Line	embryonic stem cell
17	chr2:76797200-76797600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr2:76797400-76797600	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr2:76797600-76798600	Weak transcription	H9 Cell Line	embryonic stem cell
20	chr2:76797600-76798800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
21	chr2:76797600-76800000	Enhancers	HUES64 Cell Line	embryonic stem cell
22	chr2:76797800-76798200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
23	chr2:76798200-76799000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
24	chr2:76798200-76799400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr2:76798200-76800000	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr2:76798600-76799200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr2:76798600-76799200	Enhancers	H9 Cell Line	embryonic stem cell
28	chr2:76798600-76799800	Enhancers	iPS-20b Cell Line	embryonic stem cell
29	chr2:76798800-76799000	Enhancers	H1 Cell Line	embryonic stem cell
30	chr2:76798800-76800000	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr2:76798800-76800600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr2:76799000-76799800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
33	chr2:76799000-76799800	Weak transcription	H1 Cell Line	embryonic stem cell
34	chr2:76799200-76799600	Weak transcription	H9 Cell Line	embryonic stem cell
35	chr2:76799200-76800000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr2:76799600-76800200	Enhancers	H9 Cell Line	embryonic stem cell
37	chr2:76799800-76800200	Enhancers	H1 Cell Line	embryonic stem cell
38	chr2:76799800-76800200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
39	chr2:76799800-76800600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
40	chr2:76800000-76800200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
41	chr2:76800000-76800200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
42	chr2:76800000-76800200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
43	chr2:76800000-76800600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
44	chr2:76800000-76800800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
45	chr2:76800200-76800400	Enhancers	HUES6 Cell Line	embryonic stem cell
46	chr2:76800200-76800400	Enhancers	HUES64 Cell Line	embryonic stem cell
47	chr2:76800200-76800400	Enhancers	iPS-20b Cell Line	embryonic stem cell
48	chr2:76800400-76800600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
49	chr2:76800400-76800600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
50	chr2:76800400-76800600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links